Login
$FATN
$5.20 +$0.08 (1.56%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q1 FY2027
As of Jun 30, 2026
Q4 FY2026
As of Mar 31, 2026
Q3 FY2026
As of Dec 31, 2025
Q2 FY2026
As of Sep 30, 2025
Q1 FY2026
As of Jun 30, 2025
Q4 FY2025
As of Mar 31, 2025
ASSETS
Current assets:
Cash and cash equivalents
Cash
Accounts receivable, net
Inventory
Other current assets
Contracts receivable - current, net
Total current assets
Property and equipment, net
Intangible assets, net
Operating lease right-of-use assets, net
Contracts receivable - non current, net
Contracts receivable - non-current, net
Other assets
Deferred tax asset
Total assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
Accrued expenses and other current liabilities
Deferred revenue
Operating lease liabilities, current
Notes payable, current
Total current liabilities
Notes payable, non-current
Operating lease liabilities, non-current
Other non-current liabilities
Total liabilities
Stockholders’ equity:
Common stock, -no par value; 50,000,000 shares authorized; 14,125,468 and 14,024,468 shares issued and outstanding as of June 30, 2026 and March 31, 2026, respectively
Additional paid-in capital
Retained earnings
Accumulated other comprehensive income
Total stockholders’ equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support